Cargando…
Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
Autores principales: | Vajavaara, Heli, Ekeblad, Frida, Holte, Harald, Jørgensen, Judit, Leivonen, Suvi-Katri, Berglund, Mattias, Kamper, Peter, Møller, Holger J., d’Amore, Francesco, Molin, Daniel, Enblad, Gunilla, Ludvigsen, Maja, Glimelius, Ingrid, Leppä, Sirpa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409034/ https://www.ncbi.nlm.nih.gov/pubmed/33764002 http://dx.doi.org/10.3324/haematol.2020.278182 |
Ejemplares similares
-
Low lymphocyte‐to‐monocyte ratio predicts poor outcome in high‐risk aggressive large B‐cell lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2022) -
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2021) -
Testicular Diffuse Large B-Cell Lymphoma—Clinical, Molecular, and Immunological Features
por: Pollari, Marjukka, et al.
Publicado: (2021) -
Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
por: Autio, Matias, et al.
Publicado: (2020) -
MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma
por: Leivonen, Suvi-Katri, et al.
Publicado: (2017)